Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Fusion Pharmaceuticals Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 31 | 34 | +3 |
| Shares | 27.9M | 26.6M | −1.28M (−4.6%) |
| Value | $69.4M | $80.3M | +$10.9M (+15.8%) |
New holders (8)
Institutions that held Fusion Pharmaceuticals Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 659,992 | $1.99M | 0.04% |
| Citadel Advisors LLC | 28,494 | $86.0K | 0.00% |
| UBS Oconnor LLC | 17,286 | $52.0K | 0.00% |
| Renaissance Technologies LLC | 16,800 | $51.0K | 0.00% |
| Prudential Financial Inc | 14,600 | $44.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 2,900 | $9.00K | 0.00% |
| Simplex Trading, LLC | 100 | $0 | 0.00% |
| Paragon Wealth Strategies, LLC | 30 | $0 | 0.00% |
Sold out (5)
Institutions that held Fusion Pharmaceuticals Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Perceptive Advisors LLC | 1,052,445 | $2.62M |
| Rock Springs Capital Management LP | 809,854 | $2.02M |
| Millennium Management LLC | 11,722 | $29.0K |
| Tower Research Capital LLC (TRC) | 3,259 | $8.00K |
| Heritage Financial Services, LLC | 1,000 | $2.00K |